199 related articles for article (PubMed ID: 23425199)
1. Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors.
Lodola A; Capoferri L; Rivara S; Tarzia G; Piomelli D; Mulholland A; Mor M
J Med Chem; 2013 Mar; 56(6):2500-12. PubMed ID: 23425199
[TBL] [Abstract][Full Text] [Related]
2. Insights into the mechanism and inhibition of fatty acid amide hydrolase from quantum mechanics/molecular mechanics (QM/MM) modelling.
Lodola A; Mor M; Sirirak J; Mulholland AJ
Biochem Soc Trans; 2009 Apr; 37(Pt 2):363-7. PubMed ID: 19290863
[TBL] [Abstract][Full Text] [Related]
3. Nonempirical energetic analysis of reactivity and covalent inhibition of fatty acid amide hydrolase.
Chudyk EI; Dyguda-Kazimierowicz E; Langner KM; Sokalski WA; Lodola A; Mor M; Sirirak J; Mulholland AJ
J Phys Chem B; 2013 Jun; 117(22):6656-66. PubMed ID: 23654226
[TBL] [Abstract][Full Text] [Related]
4. Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure.
Lodola A; Rivara S; Mor M
Adv Protein Chem Struct Biol; 2011; 85():1-26. PubMed ID: 21920320
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
6. Understanding the role of carbamate reactivity in fatty acid amide hydrolase inhibition by QM/MM mechanistic modelling.
Lodola A; Capoferri L; Rivara S; Chudyk E; Sirirak J; Dyguda-Kazimierowicz E; Andrzej Sokalski W; Mileni M; Tarzia G; Piomelli D; Mor M; Mulholland AJ
Chem Commun (Camb); 2011 Mar; 47(9):2517-9. PubMed ID: 21240393
[TBL] [Abstract][Full Text] [Related]
7. The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues.
Clapper JR; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
Pharmacol Res; 2006 Nov; 54(5):341-4. PubMed ID: 16935521
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
[TBL] [Abstract][Full Text] [Related]
9. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
Bosier B; Muccioli GG; Lambert DM
Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
Li H; Wood JT; Whitten KM; Vadivel SK; Seng S; Makriyannis A; Avraham HK
Br J Pharmacol; 2013 Oct; 170(3):489-505. PubMed ID: 23347118
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation.
Mileni M; Kamtekar S; Wood DC; Benson TE; Cravatt BF; Stevens RC
J Mol Biol; 2010 Jul; 400(4):743-54. PubMed ID: 20493882
[TBL] [Abstract][Full Text] [Related]
12. QM/MM modelling of oleamide hydrolysis in fatty acid amide hydrolase (FAAH) reveals a new mechanism of nucleophile activation.
Lodola A; Mor M; Hermann JC; Tarzia G; Piomelli D; Mulholland AJ
Chem Commun (Camb); 2005 Sep; (35):4399-401. PubMed ID: 16136230
[TBL] [Abstract][Full Text] [Related]
13. Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity.
Ahn K; Johnson DS; Fitzgerald LR; Liimatta M; Arendse A; Stevenson T; Lund ET; Nugent RA; Nomanbhoy TK; Alexander JP; Cravatt BF
Biochemistry; 2007 Nov; 46(45):13019-30. PubMed ID: 17949010
[TBL] [Abstract][Full Text] [Related]
14. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
Naidu PS; Booker L; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Apr; 329(1):48-56. PubMed ID: 19118134
[TBL] [Abstract][Full Text] [Related]
15. Structure-property relationships of a class of carbamate-based fatty acid amide hydrolase (FAAH) inhibitors: chemical and biological stability.
Vacondio F; Silva C; Lodola A; Fioni A; Rivara S; Duranti A; Tontini A; Sanchini S; Clapper JR; Piomelli D; Mor M; Tarzia G
ChemMedChem; 2009 Sep; 4(9):1495-504. PubMed ID: 19554599
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
Hoyer FF; Khoury M; Slomka H; Kebschull M; Lerner R; Lutz B; Schott H; Lütjohann D; Wojtalla A; Becker A; Zimmer A; Nickenig G
J Mol Cell Cardiol; 2014 Jan; 66():126-32. PubMed ID: 24286707
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes.
Alexander JP; Cravatt BF
Chem Biol; 2005 Nov; 12(11):1179-87. PubMed ID: 16298297
[TBL] [Abstract][Full Text] [Related]
18. ω-Imidazolyl- and ω-Tetrazolylalkylcarbamates as Inhibitors of Fatty Acid Amide Hydrolase: Biological Activity and in vitro Metabolic Stability.
Terwege T; Hanekamp W; Garzinsky D; König S; Koch O; Lehr M
ChemMedChem; 2016 Feb; 11(4):429-43. PubMed ID: 26732805
[TBL] [Abstract][Full Text] [Related]
19. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
20. Different Routes to Inhibit Fatty Acid Amide Hydrolase: Do All Roads Lead to the Same Place?
Giacovazzo G; Bisogno T; Piscitelli F; Verde R; Oddi S; Maccarrone M; Coccurello R
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
